Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
TBPH Quote, Financials, Valuation and Earnings
Last price:
$18.75
Seasonality move
:
0.09%
Day range:
$18.50 - $18.81
52-week range:
$7.90 - $20.33
Dividend yield:
0%
P/E ratio:
33.30x
P/S ratio:
11.75x
P/B ratio:
4.08x
Volume:
253.9K
Avg. volume:
573.7K
1-year change:
90.15%
Market cap:
$949.1M
Revenue:
$64.4M
EPS (TTM):
$0.56
Earnings Data
Next earnings date for TBPH
Feb 26
2026
Most recent earnings per share
$0.07
Beat by $0.12
(Nov 10/2025)
Consensus Estimate
-$0.05
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TBPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $43M | -- | -- | -- | -- |
| 11/10/2025 | Q3 | $19.9M | $20M | $0.07 | -$0.05 | $0.12 |
| 08/12/2025 | Q2 | $26M | $26.2M | $1.08 | -$0.13 | $1.21 |
| 05/12/2025 | Q1 | $15.6M | $15.4M | -$0.27 | -$0.09 | -$0.18 |
| 02/26/2025 | Q4 | $17.1M | $18.8M | -$0.31 | -$0.08 | -$0.23 |
| 11/12/2024 | Q3 | $15.4M | $16.9M | -$0.26 | -$0.10 | -$0.16 |
| 08/05/2024 | Q2 | $15.3M | $14.3M | -$0.34 | -$0.07 | -$0.27 |
| 05/13/2024 | Q1 | $14M | $14.5M | -$0.24 | -$0.12 | -$0.12 |
| 02/26/2024 | Q4 | $17.6M | $17.6M | -$0.17 | -$0.00 | -$0.17 |
| 11/07/2023 | Q3 | -- | $15.7M | -$0.17 | -- | -- |
| 08/07/2023 | Q2 | -- | $13.7M | -$0.28 | -- | -- |
| 05/08/2023 | Q1 | -- | $10.4M | -$0.35 | -- | -- |
| 02/27/2023 | Q4 | -- | $14.6M | -$0.15 | -- | -- |
| 11/30/2022 | Q4 | -- | -- | $0.01 | -- | -- |
| 11/07/2022 | Q3 | -- | $12.5M | -$2.97 | -- | -- |
| 08/04/2022 | Q2 | -- | $11.1M | -$0.11 | -- | -- |
| 05/05/2022 | Q1 | -- | $13.2M | -$0.34 | -- | -- |
| 02/23/2022 | Q4 | -- | $14.9M | -$0.43 | -- | -- |
| 11/03/2021 | Q3 | -- | $13.2M | -$0.48 | -- | -- |
| 08/03/2021 | Q2 | -- | $12.9M | -$0.80 | -- | -- |
| 05/04/2021 | Q1 | -- | $14.3M | -$1.24 | -- | -- |
| 02/23/2021 | Q4 | -- | $18.7M | -$0.92 | -- | -- |
| 11/05/2020 | Q3 | -- | $18.3M | -$1.16 | -- | -- |
| 08/06/2020 | Q2 | -- | $15M | -$1.00 | -- | -- |
| 05/07/2020 | Q1 | -- | $19.9M | -$1.40 | -- | -- |
| 02/24/2020 | Q4 | -- | $29.5M | -$1.17 | -- | -- |
| 11/05/2019 | Q3 | -- | $12.4M | -$1.05 | -- | -- |
| 07/31/2019 | Q2 | -- | $26.2M | -$0.72 | -- | -- |
| 05/07/2019 | Q1 | -- | $5.3M | -$1.32 | -- | -- |
| 02/26/2019 | Q4 | -- | $15.7M | -$0.92 | -- | -- |
| 11/06/2018 | Q3 | -- | $12.8M | -$1.10 | -- | -- |
| 08/01/2018 | Q2 | -- | $23.5M | -$0.76 | -- | -- |
| 05/08/2018 | Q1 | -- | $8.3M | -$1.22 | -- | -- |
| 02/27/2018 | Q4 | -- | $4.5M | -$1.64 | -- | -- |
| 11/07/2017 | Q3 | -- | $4.3M | -$1.27 | -- | -- |
| 08/08/2017 | Q2 | -- | $3.5M | -$1.27 | -- | -- |
| 05/08/2017 | Q1 | -- | $3.1M | -$1.27 | -- | -- |
| 02/27/2017 | Q4 | -- | $5.7M | -$1.36 | -- | -- |
| 11/08/2016 | Q3 | -- | $19.1M | -$0.73 | -- | -- |
| 08/08/2016 | Q2 | -- | $5.5M | -$1.06 | -- | -- |
| 05/09/2016 | Q1 | -- | $18.4M | -$1.10 | -- | -- |
| 03/09/2016 | Q4 | -- | $3.9M | -$1.23 | -- | -- |
Theravance Biopharma, Inc. Earnings Questions
-
How Much did Theravance Biopharma, Inc. Generate in Revenue Last Quarter?
Theravance Biopharma, Inc. reported $20M worth of top line sales in its most recent quarter.
-
Did Theravance Biopharma, Inc. Beat Earnings Last Quarter?
Theravance Biopharma, Inc. announced earnings per share of $0.07 which represents a beat of analyst forecast a -$0.05 per share.
-
Is Theravance Biopharma, Inc. Profitable?
Theravance Biopharma, Inc. reported $18.6M that represents $0.36 per share over the last quarter.
-
What is the Analyst Consensus for Theravance Biopharma, Inc. EPS Next Year?
Theravance Biopharma, Inc.'s earnings are forecast to decrease from -$1.16 per share to -$0.42 per share next year representing a decrease of -90.48%.
-
When is Theravance Biopharma, Inc.'s Earnings Date?
Theravance Biopharma, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
